| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 221.1MM | +4% |
| Gross Profit | 178.8MM | +5% |
| Cost Of Revenue | 42.3MM | -0% |
| Operating Income | 24.2MM | +38% |
| Operating Expenses | 154.5MM | +1% |
| Net Income | 16.8MM | +48% |
| G&A | 58.7MM | -7% |
| Interest Expense | 145K | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
USANA Health Sciences, Inc., a leader in global nutrition, was recently honored with the Platinum Healthy Worksite award from Utah Worksite Wellness Council (UWWC).
USANA Health Sciences, Inc. ( NYSE:USNA ), might not be a large cap stock, but it received a lot of attention from a...
SALT LAKE CITY, April 10, 2024--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institut
USANA Health Sciences, a global cellular nutrition company, was recently recognized at the prestigious Korea Medical Healthcare Awards in the multivitamin category for the sixth consecutive year and the weight management category for the fourth consecutive year.
Key Insights Given the large stake in the stock by institutions, USANA Health Sciences' stock price might be vulnerable...
Indivior (INDV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
As the business world evolves at an unprecedented rate, the need for individuals who possess a robust growth mindset has never been more critical. Recent findings underscore that companies fostering a culture of continuous learning and adaptability outperform their competitors significantly.
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
On March 11, 2024, Kevin Guest, the Executive Chairman of the Board of Usana Health Sciences Inc (NYSE:USNA), sold 11,011 shares of the company.
Robert Sinnott, the Chief Scientific Officer of Usana Health Sciences Inc (NYSE:USNA), has sold 3,945 shares of the company on March 5, 2024, according to a recent SEC filing.